Thrivent Financial For Lutherans Codexis, Inc. Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$1.54 - $3.37 $3,794 - $8,303
-2,464 Reduced 4.66%
50,456 $154,000
Q2 2023

Aug 14, 2023
SELL
$2.21 - $4.43 $5,737 - $11,500
-2,596 Reduced 4.68%
52,920 $148,000
Q1 2023

May 17, 2023
BUY
$3.81 - $6.76 $211,515 - $375,288
55,516 New
55,516 $230,000

Others Institutions Holding CDXS

# of Institutions
125
Shares Held
59.9M
Call Options Held
25.9K
Put Options Held
20.1K
View Full List

About CODEXIS, INC.

CDXS Quotes by TradingView
  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email